Panacea Biotec Ltd.
BSE: 531349 | Sector: Health care |
NSE: PANACEABIO | ISIN Code: INE922B01023 |
BSE 00:00 | 24 May | 147.85 |
1.55 (1.06%) |
OPEN
148.50 |
HIGH
155.00 |
LOW
145.50 |
NSE 00:00 | 24 May | 147.25 |
0.30 (0.20%) |
OPEN
148.40 |
HIGH
154.60 |
LOW
145.45 |
OPEN | 148.50 |
PREVIOUS CLOSE | 146.30 |
VOLUME | 7358 |
52-Week high | 453.70 |
52-Week low | 135.45 |
P/E | |
Mkt Cap.(Rs cr) | 906 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Panacea Biotec Ltd.
India's leading research-based health management company with established research manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL) which was incorporated on 2nd February 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic ...> More
Panacea Biotec Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
906 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 75.00 | |
Latest Dividend Date | 19 Sep 2011 | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 67.77 |
P/B Ratio | (![]() |
[*S] | 2.18 |
News
Announcement
-
Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Y
-
Board Meeting Intimation for For Approving The Standalone And Consolidated Audited Financial Results
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Statement Of Investor Complaints For The Quarter Ended March 2022
Panacea Biotec Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 140.73 | 168.27 | -16.37 |
Other Income | 1680.26 | 4.9 | 34191.02 |
Total Income | 1820.99 | 173.17 | 951.56 |
Total Expenses | 170.92 | 167.33 | 2.15 |
Operating Profit | 1650.07 | 5.84 | 28154.62 |
Net Profit | 1237.47 | -54.14 | 2385.69 |
Equity Capital | 6.13 | 6.13 | - |
Panacea Biotec Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Suven Life Scie. | 78.35 | -1.01 | 1139.21 |
Kopran | 227.10 | 0.58 | 1094.85 |
TTK Healthcare | 741.40 | -1.64 | 1047.60 |
Panacea Biotec | 147.85 | 1.06 | 906.32 |
Bajaj Healthcare | 318.20 | 1.29 | 878.23 |
RPG LifeScience. | 494.60 | -0.75 | 817.94 |
Jagsonpal Pharma | 307.85 | -0.68 | 806.57 |
Panacea Biotec Ltd - SHAREHOLDING PATTERN
|
|
Panacea Biotec Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 2.64% | 2.22% | -0.49% | -0.83% |
1 Month | -12.15% | -12.46% | -5.50% | -6.10% |
3 Month | -20.70% | -21.02% | -0.88% | -0.76% |
6 Month | -19.38% | -19.60% | -7.35% | -7.41% |
1 Year | -61.78% | -61.70% | 6.71% | 6.10% |
3 Year | -17.98% | -17.25% | 37.07% | 36.15% |
Panacea Biotec Ltd - STOCK STRENGTH
Today's Low/High | 145.50 | 155.00 | |
Week Low/High | 139.60 | 177.00 | |
Month Low/High | 135.45 | 177.00 | |
YEAR Low/High | 135.45 | 454.00 | |
All TIME Low/High | 3.07 | 487.00 |
Quick Links for Panacea Biotec:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices